Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 16Tumor-Agnostic 1Sarcoma 1Endocrine 1

Conditions

Adrenal Gland Neoplasms 1Adrenal Gland Diseases 1

Interventions

Everolimus 61lutetium Lu 177 dotatate 53Magnetic Resonance Spectroscopy 39pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 25lanreotide 24gallium Ga 68 dotatate 24cabozantinib 22pasireotide 21lenvatinib 203-Iodobenzylguanidine 20Etoposide 19Sunitinib 18Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18surufatinib 16Bevacizumab 16trametinib 15dabrafenib 15Sorafenib 14Doxorubicin 14Ipilimumab 13Thyrotropin Alfa 12Surgical Procedures, Operative 12Injections 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endosonography × Endocrine × Clear all
NCT03327142 2017-10-31

EUS-guided FNA in the Study of the Adrenal Gland

Hospital Universitari de Bellvitge

Completed
204 enrolled
Endocrine

Adrenal Gland Diseases, Adrenal Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡